<!DOCTYPE pdf2xml SYSTEM "pdf2xml.dtd">
<pdf2xml producer="poppler" version="23.04.0">
<page number="1" position="absolute" top="0" left="0" height="792" width="612">
	<fontspec id="font0" size="9" family="Arial,Italic" color="#000000"/>
	<fontspec id="font1" size="9" family="Arial" color="#000000"/>
	<fontspec id="font2" size="9" family="Arial,Bold" color="#000000"/>
	<fontspec id="font3" size="7" family="Arial,Italic" color="#000000"/>
	<fontspec id="font4" size="10" family="Giovanni-Book" color="#000000"/>
	<fontspec id="font5" size="10" family="Symbol" color="#000000"/>
	<fontspec id="font6" size="10" family="Giovanni-BookItalic,Italic" color="#000000"/>
	<fontspec id="font7" size="11" family="GillSans,Bold" color="#000000"/>
	<fontspec id="font8" size="9" family="GillSans,BoldItalic" color="#000000"/>
	<fontspec id="font9" size="8" family="GillSans,Bold" color="#000000"/>
	<fontspec id="font10" size="8" family="GillSans,BoldItalic" color="#000000"/>
	<fontspec id="font11" size="8" family="GillSans" color="#000000"/>
	<fontspec id="font12" size="6" family="GillSans,Bold" color="#000000"/>
	<fontspec id="font13" size="8" family="Symbol" color="#000000"/>
<text top="41" left="55" width="126" height="10" font="font0" id="p1_t1" reading_order_no="0" segment_no="0" tag_type="title">BMC Pharmacology 2005, 5 :15<i>BMC Pharmacology</i></text>
<text top="41" left="368" width="186" height="10" font="font1" id="p1_t2" reading_order_no="1" segment_no="1" tag_type="text">http://www.biomedcentral.com/1471-2210/5/15</text>
<text top="756" left="503" width="51" height="10" font="font1" id="p1_t3" reading_order_no="123" segment_no="18" tag_type="text">Page 2 of 10<b>5</b></text>
<text top="769" left="432" width="122" height="8" font="font3" id="p1_t4" reading_order_no="124" segment_no="19" tag_type="text">(page number not for citation purposes)</text>
<text top="372" left="55" width="241" height="9" font="font4" id="p1_t5" reading_order_no="67" segment_no="8" tag_type="text">Cumulative data suggest a role for reactive oxygen metab-</text>
<text top="384" left="55" width="241" height="9" font="font4" id="p1_t6" reading_order_no="68" segment_no="8" tag_type="text">olites as one of the postulated mechanisms in the patho-</text>
<text top="395" left="55" width="241" height="9" font="font4" id="p1_t7" reading_order_no="69" segment_no="8" tag_type="text">genesis of CsA nephrotoxicity. CsA results in enhanced<i>(page number not for citation purposes)</i></text>
<text top="407" left="55" width="241" height="9" font="font4" id="p1_t8" reading_order_no="70" segment_no="8" tag_type="text">generation of hydrogen peroxide in cultured hepatocytes</text>
<text top="419" left="55" width="241" height="9" font="font4" id="p1_t9" reading_order_no="71" segment_no="8" tag_type="text">[5] and mesangial cells [6,7]. In vitro and in vivo studies</text>
<text top="431" left="55" width="241" height="9" font="font4" id="p1_t10" reading_order_no="72" segment_no="8" tag_type="text">indicate that CsA enhances lipid peroxidation, reduces</text>
<text top="442" left="55" width="241" height="9" font="font4" id="p1_t11" reading_order_no="73" segment_no="8" tag_type="text">renal microsomal NADPH cytochrome P450, and renal</text>
<text top="454" left="55" width="241" height="9" font="font4" id="p1_t12" reading_order_no="74" segment_no="8" tag_type="text">reduced/oxidized glutathione ratio (GSH/GSSG) in kid-<a href="">[5] and mesangial cells [6,7]. In vit</a>ro and in vivo studies</text>
<text top="466" left="55" width="241" height="9" font="font4" id="p1_t13" reading_order_no="75" segment_no="8" tag_type="text">ney cortex as well as renal microsomes and mitochondria</text>
<text top="475" left="55" width="241" height="13" font="font4" id="p1_t14" reading_order_no="76" segment_no="8" tag_type="text">[8-11]. Antioxidants such as α -tocopherol, ascorbate, sili-</text>
<text top="489" left="55" width="241" height="9" font="font4" id="p1_t15" reading_order_no="77" segment_no="8" tag_type="text">binin, lazaroid, propionyl carnitine and superoxide dis-</text>
<text top="501" left="55" width="241" height="9" font="font4" id="p1_t16" reading_order_no="78" segment_no="8" tag_type="text">mutase/catalase, have been shown to ameliorate</text>
<text top="513" left="55" width="178" height="9" font="font4" id="p1_t17" reading_order_no="79" segment_no="8" tag_type="text">cyclosporine-induced renal toxicity [5,12].<a href="">[8-11]</a>. Antioxidants such as </text>
<text top="536" left="55" width="241" height="9" font="font4" id="p1_t18" reading_order_no="80" segment_no="13" tag_type="text">Current traditional Indian medicine claims the use of Cur-</text>
<text top="548" left="55" width="242" height="9" font="font6" id="p1_t19" reading_order_no="81" segment_no="13" tag_type="text">cuma longa L. (Zingiberaceae) powder against biliary disor-</text>
<text top="560" left="55" width="241" height="9" font="font4" id="p1_t20" reading_order_no="82" segment_no="13" tag_type="text">ders, anorexia, coryza, cough, diabetic wounds, hepatic</text>
<text top="572" left="55" width="241" height="9" font="font4" id="p1_t21" reading_order_no="83" segment_no="13" tag_type="text">disorder, rheumatism and sinusitis [13]. Curcumin</text>
<text top="583" left="55" width="241" height="9" font="font4" id="p1_t22" reading_order_no="84" segment_no="13" tag_type="text">(CMN) is a major component in curcuma/turmeric, being<a href="">xicity [5,12</a>].</text>
<text top="595" left="55" width="241" height="9" font="font4" id="p1_t23" reading_order_no="85" segment_no="13" tag_type="text">responsible for its biological actions. More and more</text>
<text top="607" left="55" width="241" height="9" font="font4" id="p1_t24" reading_order_no="86" segment_no="13" tag_type="text">studies now show that CMN exhibit anti-inflamma-<i>Cur-</i></text>
<text top="619" left="55" width="241" height="9" font="font4" id="p1_t25" reading_order_no="87" segment_no="13" tag_type="text">tory[14,15], anti-human immunodeficiency virus<i>cuma longa </i></text>
<text top="630" left="55" width="241" height="9" font="font4" id="p1_t26" reading_order_no="88" segment_no="13" tag_type="text">[16,17], anti-bacterial [18] and nematocidal activities</text>
<text top="642" left="55" width="241" height="9" font="font4" id="p1_t27" reading_order_no="89" segment_no="13" tag_type="text">[19]. Various in-vitro and in-vivo studies increasingly estab-<i>(Zingiberaceae) </i></text>
<text top="654" left="55" width="241" height="9" font="font4" id="p1_t28" reading_order_no="90" segment_no="13" tag_type="text">lish the antioxidant properties of CMN [20-22]. It is well</text>
<text top="666" left="55" width="241" height="9" font="font4" id="p1_t29" reading_order_no="91" segment_no="13" tag_type="text">documented that CMN scavenges superoxide anions [23],</text>
<text top="677" left="55" width="241" height="9" font="font4" id="p1_t30" reading_order_no="92" segment_no="13" tag_type="text">peroxynitrite radicals [24,25], and quenches singlet oxy-<a href="">13]</a>. Curcumin</text>
<text top="689" left="55" width="241" height="9" font="font4" id="p1_t31" reading_order_no="93" segment_no="13" tag_type="text">gen [26]. CMN has also been shown to inhibit hydrogen-</text>
<text top="701" left="55" width="149" height="9" font="font4" id="p1_t32" reading_order_no="94" segment_no="13" tag_type="text">peroxide-induced cell damage [20].</text>
<text top="372" left="313" width="241" height="9" font="font4" id="p1_t33" reading_order_no="95" segment_no="9" tag_type="text">Thus the present study was designed to examine the pos-</text>
<text top="384" left="313" width="241" height="9" font="font4" id="p1_t34" reading_order_no="96" segment_no="9" tag_type="text">sible beneficial effect of CMN in preventing the acute<a href="">ry[14</a>,<a href="">15</a>], anti-human immunodeficiency virus</text>
<text top="395" left="313" width="241" height="9" font="font4" id="p1_t35" reading_order_no="97" segment_no="9" tag_type="text">renal failure and related oxidative stress caused by chronic<a href="">[16,17]</a>, anti-bacterial <a href="">[18]</a> and nematocidal activities</text>
<text top="407" left="313" width="124" height="9" font="font4" id="p1_t36" reading_order_no="98" segment_no="9" tag_type="text">administration of CsA in rats.<a href="">[19]. Various </a></text>
<text top="431" left="313" width="36" height="10" font="font7" id="p1_t37" reading_order_no="99" segment_no="10" tag_type="title">Results<i>in-vitro </i></text>
<text top="443" left="313" width="136" height="9" font="font8" id="p1_t38" reading_order_no="100" segment_no="11" tag_type="title">Effect of CMN on renal function</text>
<text top="454" left="313" width="241" height="9" font="font4" id="p1_t39" reading_order_no="101" segment_no="12" tag_type="text">CsA treatment for 21 days significantly increased the<i>in-vivo </i></text>
<text top="466" left="313" width="241" height="9" font="font4" id="p1_t40" reading_order_no="102" segment_no="12" tag_type="text">serum creatinine and blood urea nitrogen (BUN) as com-</text>
<text top="478" left="313" width="241" height="9" font="font4" id="p1_t41" reading_order_no="103" segment_no="12" tag_type="text">pared with the control group. Chronic CMN treatment<a href="">N [20-22</a>]. It is well</text>
<text top="489" left="313" width="241" height="9" font="font4" id="p1_t42" reading_order_no="104" segment_no="12" tag_type="text">significantly and dose-dependently prevented this rise in<a href="">ns [23],</a></text>
<text top="501" left="313" width="241" height="9" font="font4" id="p1_t43" reading_order_no="105" segment_no="12" tag_type="text">BUN and serum creatinine (Table-1). Moreover, the creat-<a href="">cals [24,25], </a>and quenches singlet oxy-</text>
<text top="513" left="313" width="241" height="9" font="font4" id="p1_t44" reading_order_no="106" segment_no="12" tag_type="text">inine and urea clearance, which was markedly reduced by<a href="">n [26]</a>. CMN has also been shown to inhibit hydrogen-</text>
<text top="525" left="313" width="241" height="9" font="font4" id="p1_t45" reading_order_no="107" segment_no="12" tag_type="text">CsA-administration, was significantly and dose-depend-<a href="">ll damage [20].</a></text>
<text top="536" left="313" width="241" height="9" font="font4" id="p1_t46" reading_order_no="108" segment_no="12" tag_type="text">ently improved by CMN treatment (Table-1). However,</text>
<text top="548" left="313" width="241" height="9" font="font4" id="p1_t47" reading_order_no="109" segment_no="12" tag_type="text">CMN (15 mg/kg) per se had no effect on serum creatinine,</text>
<text top="560" left="313" width="150" height="9" font="font4" id="p1_t48" reading_order_no="110" segment_no="12" tag_type="text">BUN, creatinine and urea clearance.</text>
<text top="584" left="313" width="201" height="9" font="font8" id="p1_t49" reading_order_no="111" segment_no="14" tag_type="title">Effect of CMN on CsA-induced nitrosative stress</text>
<text top="595" left="313" width="241" height="9" font="font4" id="p1_t50" reading_order_no="112" segment_no="15" tag_type="text">Serum and tissue nitrite levels were significantly elevated<b>Results</b></text>
<text top="607" left="313" width="241" height="9" font="font4" id="p1_t51" reading_order_no="113" segment_no="15" tag_type="text">by CsA-administration. Curcumin treatment significantly<i><b>Effect of CMN on renal function</b></i></text>
<text top="619" left="313" width="241" height="9" font="font4" id="p1_t52" reading_order_no="114" segment_no="15" tag_type="text">and dose dependently improved this increase in nitrite</text>
<text top="630" left="313" width="241" height="9" font="font4" id="p1_t53" reading_order_no="115" segment_no="15" tag_type="text">levels both in serum and tissue (Table-2). However, CMN</text>
<text top="642" left="313" width="229" height="9" font="font4" id="p1_t54" reading_order_no="116" segment_no="15" tag_type="text">(15 mg/kg) per se had no effect on serum nitrite levels.</text>
<text top="666" left="313" width="206" height="9" font="font8" id="p1_t55" reading_order_no="117" segment_no="16" tag_type="title">Effect of CMN on CsA-induced lipid peroxidation</text>
<text top="677" left="313" width="241" height="9" font="font4" id="p1_t56" reading_order_no="118" segment_no="17" tag_type="text">Renal TBARS levels were markedly increased by CsA<a href="">le-1). M</a>oreover, the creat-</text>
<text top="689" left="313" width="241" height="9" font="font4" id="p1_t57" reading_order_no="119" segment_no="17" tag_type="text">administration as compared to control group. Treatment</text>
<text top="701" left="313" width="241" height="9" font="font4" id="p1_t58" reading_order_no="120" segment_no="17" tag_type="text">with curcumin produced a significant and dose-depend-</text>
<text top="713" left="313" width="241" height="9" font="font4" id="p1_t59" reading_order_no="121" segment_no="17" tag_type="text">ent reduction in TBARS in CsA-treated rats, however cur-<a href="">able-1). Howeve</a>r,</text>
<text top="724" left="313" width="175" height="9" font="font4" id="p1_t60" reading_order_no="122" segment_no="17" tag_type="text">cumin per se did not alter TBARS (Fig. 1).</text>
<text top="87" left="55" width="235" height="7" font="font9" id="p1_t61" reading_order_no="2" segment_no="2" tag_type="title">Table 1: Effect of CMN on cyclosporine-induced nephrotoxicity<i>per se </i></text>
<text top="105" left="58" width="33" height="7" font="font10" id="p1_t62" reading_order_no="3" segment_no="3" tag_type="table">Variables</text>
<text top="105" left="166" width="28" height="7" font="font10" id="p1_t63" reading_order_no="4" segment_no="3" tag_type="table">Control</text>
<text top="105" left="215" width="31" height="7" font="font10" id="p1_t64" reading_order_no="5" segment_no="3" tag_type="table">CsA (20)<i><b>Effect of CMN on CsA-induced nitrosative stress</b></i></text>
<text top="105" left="268" width="34" height="7" font="font10" id="p1_t65" reading_order_no="6" segment_no="3" tag_type="table">CMN(15)</text>
<text top="105" left="321" width="68" height="7" font="font10" id="p1_t66" reading_order_no="7" segment_no="3" tag_type="table">CsA (20)+ CMN(5)</text>
<text top="105" left="397" width="72" height="7" font="font10" id="p1_t67" reading_order_no="8" segment_no="3" tag_type="table">CsA (20)+ CMN(10)</text>
<text top="105" left="477" width="72" height="7" font="font10" id="p1_t68" reading_order_no="9" segment_no="3" tag_type="table">CsA (20)+ CMN(15)<a href="">le-2). However</a>, CMN</text>
<text top="127" left="58" width="83" height="7" font="font11" id="p1_t69" reading_order_no="10" segment_no="3" tag_type="table">Serum creatinine (mg/dl)</text>
<text top="127" left="166" width="38" height="7" font="font11" id="p1_t70" reading_order_no="11" segment_no="3" tag_type="table">0.95 ± 0.01<i>per se </i></text>
<text top="127" left="215" width="41" height="7" font="font11" id="p1_t71" reading_order_no="12" segment_no="3" tag_type="table">3.12 ± 0.17 a</text>
<text top="127" left="268" width="41" height="7" font="font11" id="p1_t72" reading_order_no="13" segment_no="3" tag_type="table">0.87 ± 0.01 b<i><b>Effect of CMN on CsA-induced lipid peroxidation</b></i></text>
<text top="127" left="321" width="46" height="7" font="font11" id="p1_t73" reading_order_no="14" segment_no="3" tag_type="table">2.00 ± 0.11 a,b</text>
<text top="127" left="397" width="41" height="7" font="font11" id="p1_t74" reading_order_no="15" segment_no="3" tag_type="table">1.5 ± 0.06 a,b</text>
<text top="127" left="477" width="46" height="7" font="font11" id="p1_t75" reading_order_no="16" segment_no="3" tag_type="table">1.00 ± 0.01 a,b</text>
<text top="137" left="58" width="99" height="7" font="font11" id="p1_t76" reading_order_no="17" segment_no="3" tag_type="table">Creatinine clearance (ml/min)</text>
<text top="137" left="166" width="38" height="7" font="font11" id="p1_t77" reading_order_no="18" segment_no="3" tag_type="table">0.76 ± 0.06<a href="">ig. 1).</a></text>
<text top="137" left="215" width="45" height="7" font="font11" id="p1_t78" reading_order_no="19" segment_no="3" tag_type="table">0.078 ± 0.05 a<b>Table 1: Effect of CMN on cyclosporine-induced nephrotoxicity</b></text>
<text top="137" left="268" width="41" height="7" font="font11" id="p1_t79" reading_order_no="20" segment_no="3" tag_type="table">0.87 ± 0.05 b<i><b>Variables</b></i></text>
<text top="137" left="321" width="46" height="7" font="font11" id="p1_t80" reading_order_no="21" segment_no="3" tag_type="table">0.44 ± 0.03 a,b<i><b>Control</b></i></text>
<text top="137" left="397" width="45" height="7" font="font11" id="p1_t81" reading_order_no="22" segment_no="3" tag_type="table">0.65 ± 0.04 a,b<i><b>CsA (20)</b></i></text>
<text top="137" left="477" width="41" height="7" font="font11" id="p1_t82" reading_order_no="23" segment_no="3" tag_type="table">0.80 ± 0.05 b<i><b>CMN(15)</b></i></text>
<text top="148" left="58" width="43" height="7" font="font11" id="p1_t83" reading_order_no="24" segment_no="3" tag_type="table">BUN (mg/dl)<i><b>CsA (20)+ CMN(5)</b></i></text>
<text top="148" left="166" width="42" height="7" font="font11" id="p1_t84" reading_order_no="25" segment_no="3" tag_type="table">24.55 ± 0.77<i><b>CsA (20)+ CMN(10)</b></i></text>
<text top="147" left="215" width="45" height="8" font="font11" id="p1_t85" reading_order_no="26" segment_no="3" tag_type="table">87.44 ± 4.37 a<i><b>CsA (20)+ CMN(15)</b></i></text>
<text top="147" left="268" width="45" height="8" font="font11" id="p1_t86" reading_order_no="27" segment_no="3" tag_type="table">26.87 ± 0.64 b</text>
<text top="147" left="321" width="50" height="8" font="font11" id="p1_t87" reading_order_no="28" segment_no="3" tag_type="table">73.65 ± 1.32 a,b</text>
<text top="147" left="397" width="45" height="8" font="font11" id="p1_t88" reading_order_no="29" segment_no="3" tag_type="table">53.21 ± 0.9 a,b</text>
<text top="147" left="477" width="52" height="8" font="font11" id="p1_t89" reading_order_no="30" segment_no="3" tag_type="table">35.89 ± 0.64 a,b<b>a</b></text>
<text top="158" left="58" width="81" height="7" font="font11" id="p1_t90" reading_order_no="31" segment_no="3" tag_type="table">Urea clearance (ml/min)</text>
<text top="158" left="166" width="38" height="7" font="font11" id="p1_t91" reading_order_no="32" segment_no="3" tag_type="table">0.58 ± 0.04<b>b</b></text>
<text top="158" left="215" width="41" height="7" font="font11" id="p1_t92" reading_order_no="33" segment_no="3" tag_type="table">0.19 ± 0.05 a</text>
<text top="158" left="268" width="41" height="7" font="font11" id="p1_t93" reading_order_no="34" segment_no="3" tag_type="table">0.61 ± 0.03 b<b>a,b</b></text>
<text top="158" left="321" width="46" height="7" font="font11" id="p1_t94" reading_order_no="35" segment_no="3" tag_type="table">0.49 ± 0.02 a,b</text>
<text top="158" left="397" width="45" height="7" font="font11" id="p1_t95" reading_order_no="36" segment_no="3" tag_type="table">0.53 ± 0.03 a,b<b>a,b</b></text>
<text top="158" left="477" width="41" height="7" font="font11" id="p1_t96" reading_order_no="37" segment_no="3" tag_type="table">0.59 ± 0.03 b</text>
<text top="180" left="58" width="493" height="7" font="font11" id="p1_t97" reading_order_no="38" segment_no="4" tag_type="text">Values are expressed mean ± mean. a = Statistical significant at P &lt; 0.05 as compared to control, b = Statistical significant at P &lt; 0.05 as compared to<b>a,b</b></text>
<text top="189" left="58" width="67" height="7" font="font11" id="p1_t98" reading_order_no="39" segment_no="4" tag_type="text">Cyclosporine (CsA)</text>
<text top="238" left="55" width="229" height="7" font="font9" id="p1_t99" reading_order_no="40" segment_no="5" tag_type="title">Table 2: Effect of CMN on cyclosporine-induced Nitrite levels</text>
<text top="256" left="59" width="33" height="7" font="font10" id="p1_t100" reading_order_no="41" segment_no="6" tag_type="table">Variables</text>
<text top="256" left="164" width="28" height="7" font="font10" id="p1_t101" reading_order_no="42" segment_no="6" tag_type="table">Control<b>a</b></text>
<text top="256" left="227" width="31" height="7" font="font10" id="p1_t102" reading_order_no="43" segment_no="6" tag_type="table">CsA (20)</text>
<text top="256" left="291" width="34" height="7" font="font10" id="p1_t103" reading_order_no="44" segment_no="6" tag_type="table">CMN(15)<b>b</b></text>
<text top="256" left="359" width="38" height="7" font="font10" id="p1_t104" reading_order_no="45" segment_no="6" tag_type="table">CsA (20)+</text>
<text top="265" left="362" width="30" height="7" font="font10" id="p1_t105" reading_order_no="46" segment_no="6" tag_type="table">CMN(5)<b>a,b</b></text>
<text top="256" left="430" width="38" height="7" font="font10" id="p1_t106" reading_order_no="47" segment_no="6" tag_type="table">CsA (20)+</text>
<text top="265" left="431" width="34" height="7" font="font10" id="p1_t107" reading_order_no="48" segment_no="6" tag_type="table">CMN(10)<b>a,b</b></text>
<text top="256" left="501" width="38" height="7" font="font10" id="p1_t108" reading_order_no="49" segment_no="6" tag_type="table">CsA (20)+</text>
<text top="265" left="502" width="34" height="7" font="font10" id="p1_t109" reading_order_no="50" segment_no="6" tag_type="table">CMN(15)<b>b</b></text>
<text top="285" left="59" width="80" height="11" font="font11" id="p1_t110" reading_order_no="51" segment_no="6" tag_type="table">Serum Nitrite( µ mol/ml)</text>
<text top="287" left="162" width="32" height="7" font="font11" id="p1_t111" reading_order_no="52" segment_no="6" tag_type="table">62 ± 3.72</text>
<text top="287" left="222" width="41" height="7" font="font11" id="p1_t112" reading_order_no="53" segment_no="6" tag_type="table">91.9 ± 50.6 a</text>
<text top="287" left="290" width="35" height="7" font="font11" id="p1_t113" reading_order_no="54" segment_no="6" tag_type="table">60 ± 3.15 b<b>a</b></text>
<text top="287" left="357" width="40" height="7" font="font11" id="p1_t114" reading_order_no="55" segment_no="6" tag_type="table">77 ± 4.55 a,b</text>
<text top="287" left="430" width="35" height="7" font="font11" id="p1_t115" reading_order_no="56" segment_no="6" tag_type="table">69 ± 8.75 b<b>b</b></text>
<text top="287" left="502" width="34" height="7" font="font11" id="p1_t116" reading_order_no="57" segment_no="6" tag_type="table">61 ± 3.05 b</text>
<text top="295" left="59" width="79" height="11" font="font11" id="p1_t117" reading_order_no="58" segment_no="6" tag_type="table">Tissue nitrite( µ mol/mg)<b>a,b</b></text>
<text top="298" left="153" width="50" height="7" font="font11" id="p1_t118" reading_order_no="59" segment_no="6" tag_type="table">103.518 ± 2.73</text>
<text top="297" left="216" width="53" height="8" font="font11" id="p1_t119" reading_order_no="60" segment_no="6" tag_type="table">190.656 ± 7.97 a<b>a,b</b></text>
<text top="297" left="281" width="53" height="8" font="font11" id="p1_t120" reading_order_no="61" segment_no="6" tag_type="table">101.814 ± 2.27 b</text>
<text top="297" left="348" width="58" height="8" font="font11" id="p1_t121" reading_order_no="62" segment_no="6" tag_type="table">174.704 ± 4.01 a,b<b>a,b</b></text>
<text top="297" left="421" width="54" height="8" font="font11" id="p1_t122" reading_order_no="63" segment_no="6" tag_type="table">144.79 ± 3.01 a,b</text>
<text top="297" left="490" width="58" height="8" font="font11" id="p1_t123" reading_order_no="64" segment_no="6" tag_type="table">116.912 ± 2.27 a,b</text>
<text top="320" left="59" width="490" height="7" font="font11" id="p1_t124" reading_order_no="65" segment_no="7" tag_type="text">Values are expressed mean ± mean. a = Statistical significant at P &lt; 0.05 as compared to control, b = Statistical significant at P &lt; 0.05 as compared</text>
<text top="329" left="59" width="76" height="7" font="font11" id="p1_t125" reading_order_no="66" segment_no="7" tag_type="text">to Cyclosporine (CsA)<b>a</b></text>
</page>
</pdf2xml>
